EVE Health Group Limited (ASX:EVE) has disclosed an updated Securities Trading Policy, following Board approval on 17 November 2026, in accordance with ASX Listing Rule 12.10, with the filing authorised for release by Chief Financial Officer Steven Jackson.
Key Points
- The Board approved the updated Securities Trading Policy on 17 November 2026.
- The policy applies to Key Management Personnel, defined as Directors, the CEO, the CFO, the Company Secretary, any employee reporting directly to the CEO, and any other person the Company Secretary notifies in writing.
- Closed Periods restrict trading two weeks before, and 24 hours after, the release of quarterly, half-year and annual reports, as well as during prospectus lodgement periods.
- Key Management Personnel are prohibited from hedging exposure to unvested remuneration or to Company Securities subject to a holding lock, and margin loans require prior approval.
Scope of the Updated Securities Trading Policy
According to the filing, the policy covers any purchase, sale or other dealing in securities of the company and its subsidiaries, including shares, options, performance rights, and any derivative over them, collectively defined as Company Securities. The policy applies to dealings made directly or through Associates, including nominees, agents, family members, family trusts, family companies, and self-managed superannuation funds. The filing states that Key Management Personnel are encouraged to be long-term holders of Company Securities, and that in some respects the policy goes beyond the strict requirements of the Corporations Act 2001 (Cth).
Insider Trading Prohibitions and Price Sensitive Information
The policy states that insider trading is a criminal offence that may also result in civil liability. A person is in breach where they possess information not generally available to the market that would be likely to have a material effect on the price or value of Company Securities, and they buy or sell Company Securities, procure someone else to do so, or pass on that information to a third party. The filing lists examples of potentially price sensitive information, including major acquisitions or disposals, financial results materially exceeding or falling short of market expectations, material changes in debt or cash flow, significant product or regulatory developments, proposed capital raisings, major litigation, and significant changes to the Board or senior management.
Closed Periods, Short-Term Trading and Permitted Exceptions
The policy establishes Closed Periods during which Key Management Personnel must not deal in Company Securities. These cover two weeks before and 24 hours after each quarterly activities report and Appendix 4C, half-year report, and annual report, as well as two weeks before lodgement of a prospectus until it closes for applications. The Chair or CEO may impose additional restrictions at any time. Short-term or speculative trading is prohibited. Permitted exceptions include transferring securities into a superannuation fund of which the person is a beneficiary, or investing in a fund where assets are managed at the discretion of a third party, provided no price sensitive information is held.



Please wait processing your request...